|
MechanismHIV p17 matrix protein inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
EFFICACY And TOLLERABILITY Of TREATMENT for inhalation WITH L-ASA IN PATIENTS WITH MILD Or MODERATED ASTHMA IN COMPARISON WITH CORTICOSTEROID for inhalation
100 Clinical Results associated with Medestea Research & Production SpA
0 Patents (Medical) associated with Medestea Research & Production SpA
100 Deals associated with Medestea Research & Production SpA
100 Translational Medicine associated with Medestea Research & Production SpA